![]() |
市場調查報告書
商品編碼
1836232
生物銀行冷藏設備市場-全球和區域分析:按服務細分、最終用戶和區域進行分析和預測(2024-2033 年)Biobanking Cold Storage Equipment Market - A Global and Regional Analysis: Focus on Offering, End User, and Region - Analysis and Forecast, 2024-2033 |
||||||
全球生物銀行冷藏設備市場預計將從 2023 年的 14.106 億美元強勁成長。
預計到 2033 年將達到 28.899 億美元,2024 年至 2033 年的複合年成長率為 7.55%。
這一市場的強勁成長是由對人體組織、血液和 DNA 等生物樣本長期儲存日益成長的需求所驅動的。這些樣本在基因組學、製藥和生物技術等研究領域中發揮著至關重要的作用,推動了對先進冷藏解決方案的需求。市場細分為設備、配件和耗材、軟體和服務。其中,設備部分佔據主導地位,冷凍庫、超冷藏系統和冰箱成為生物庫的重要組成部分。溫度控制系統的技術創新和對個人化醫療日益成長的興趣進一步推動了對高品質和可靠冷藏設備的需求。此外,對生物庫更嚴格的監管要求預計將推動對堅固安全的儲存設施的需求。此外,對精準醫療研發的投資增加也在推動市場成長。
| 主要市場統計數據 | |
|---|---|
| 預測期 | 2024-2033 |
| 2024年評估 | 15.9億美元 |
| 2033年預測 | 28.899億美元 |
| 複合年成長率 | 7.55% |
區域細分
歐洲
歐洲仍然是全球生物銀行冷藏設備市場的領先地區。憑藉其強大的醫療基礎設施、對研發的高度重視以及政府對生命科學領域的支持,該地區擁有世界上數量最多的生物樣本庫。英國、德國、法國和荷蘭等國家是主要貢獻者,在精準醫療、基因組學和生物醫學研究方面投入了大量資金。此外,歐洲嚴格的生物樣本庫法規環境必將增加對高品質冷藏解決方案的需求,從而進一步推動市場成長。大量主要企業和研究機構的存在也鞏固了歐洲在市場上的主導地位。
北美洲
北美,尤其是美國,在全球市場佔有重要佔有率。該地區憑藉先進的技術力、強大的製藥業以及對生命科學研究的大量投資,正在推動市場擴張。個人化醫療的日益成長以及主要醫療和學術研究機構的活動,正在推動對可靠低溫儲存設備的需求。鼓勵建立生物樣本庫的政府優惠政策也促進了市場成長。
亞太地區
亞太地區是成長最快的地區。生物技術和製藥行業的快速發展,以及不斷增加的研究投入,推動了中國、日本、印度和韓國等國家生物樣本庫的發展。這些國家正在建造生物樣本庫基礎設施,以滿足日益成長的基因組學研究、診斷和精準醫療需求。醫療成本的上漲和臨床試驗的增加也刺激了對先進冷藏解決方案的需求。隨著該地區持續投資於生物銀行建設,對高效、擴充性冷藏設備的需求預計將進一步成長。
中東和非洲
中東和非洲地區是一個發展中市場。儘管目前的市佔率相對較小,但阿拉伯聯合大公國和沙烏地阿拉伯等國家正在大力投資生物技術和基因組學,並建造生物樣本庫基礎設施。研究合作的增加以及人們對生物樣本庫在醫學研究中重要性的認知不斷提高,正在推動該地區對冷藏解決方案的需求。
拉丁美洲
拉丁美洲生物銀行冷藏設備市場正穩定成長,其中巴西、墨西哥和阿根廷等國家領先。政府支持和不斷擴張的生物技術產業正在推動市場擴張。然而,一些國家的經濟挑戰和研發投入不足限制了其成長。儘管如此,隨著醫療和科研基礎設施的改善,冷藏解決方案的需求預計將持續成長。
本報告研究了全球生物銀行冷藏設備市場,並總結了主要趨勢、市場影響因素分析、法律規範、市場規模趨勢和預測、各個細分市場和主要國家的詳細分析、競爭格局以及主要企業的概況。
This report can be delivered within 1 working day.
Introduction of Biobanking Cold Storage Equipment Market
The global biobanking cold storage equipment market, valued at $1,410.6 million in 2023, is on a robust growth trajectory and is anticipated to reach $2,889.9 million by 2033. This market is expected to expand at a compound annual growth rate (CAGR) of 7.55% between 2024 and 2033. The global biobanking cold storage equipment market is experiencing robust growth due to the increasing demand for the long-term preservation of biological samples, such as human tissues, blood, and DNA. These samples are pivotal in research areas such as genomics, pharmaceuticals, and biotechnology, fueling the need for advanced cold storage solutions. The market is segmented by offerings, including equipment, accessories and consumables, software, and services. Among these, the equipment segment dominates, with freezers, cryogenic storage systems, and refrigerators being essential components in biobanks. Technological advancements in temperature control systems, along with the growing trend towards personalized medicine, have heightened the need for high-quality and reliable cold storage solutions. Furthermore, as regulatory requirements for biobanks become more stringent, the demand for robust and secure cold storage equipment is expected to rise. The increasing investment in research and development of precision medicine further contributes to the market's expansion.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $1,500.9 Million |
| 2033 Forecast | $2,889.9 Million |
| CAGR | 7.55% |
Regional Segmentation:
Europe
Europe remains the leading region in the global biobanking cold storage equipment market. The region is home to the highest number of biobanks, driven by a robust healthcare infrastructure, a strong focus on research and development, and government support for life sciences initiatives. Countries like the U.K, Germany, France, and the Netherlands are key contributors, with substantial investments in precision medicine, genomics, and biomedical research. Additionally, Europe's strict regulatory environment for biobanks ensures the demand for high-quality cold storage solutions, further boosting market growth. The presence of major players and research institutions also strengthens Europe's dominant position in the market.
North America
North America, particularly the U.S., holds a significant share of the global biobanking cold storage equipment market. The region benefits from advanced technological capabilities, a strong pharmaceutical industry, and substantial investments in life sciences research. The growing trend toward personalized medicine, alongside major healthcare organizations and academic research institutions, drives demand for reliable cold storage equipment. The region also benefits from favorable government policies that encourage the establishment of biobanks, thus contributing to market growth.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for biobanking cold storage equipment. Rapid advancements in biotechnology and pharmaceuticals, coupled with increasing research investments, drive the growth of biobanks in countries like China, Japan, India, and South Korea. These countries are expanding their biobanking infrastructure to support the growing demand for genomics research, diagnostics, and precision medicine. The rise in healthcare expenditures and the increasing number of clinical trials in the region also stimulate demand for advanced cold storage solutions. As the region continues to invest in biobanking capabilities, the demand for efficient and scalable cold storage equipment will continue to rise.
Middle East & Africa
The Middle East and Africa (MEA) region is a developing market for biobanking cold storage equipment. While currently holding a smaller market share, countries like the UAE and Saudi Arabia are advancing their biobanking infrastructure, supported by growing investments in biotechnology and genomics. Increasing research collaborations and awareness about the importance of biobanks in medical research are driving demand for cold storage solutions in the region.
Latin America
Latin America is experiencing steady growth in the biobanking cold storage equipment market, particularly in countries like Brazil, Mexico, and Argentina. Government initiatives and a growing biotechnology sector are contributing to market expansion. However, economic challenges and lower research investments in some countries limit growth, though demand for cold storage solutions is expected to rise as the region develops its healthcare and research infrastructure.
Recent Developments in the Global Biobanking Cold Storage Equipment Market
How can this report add value to an organization?
Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.
Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth markets such as Asia-Pacific, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions like North America and Europe, capitalizing on the increasing need for advanced cold storage solutions.
Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
Primary Research:
The primary sources involve industry experts in biobanking cold storage equipment, including the market players offering biobanking cold storage equipment. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
Secondary Research
Open Sources
The key data points taken from the secondary sources include:
Key Market Players and Competition Synopsis
The competitive landscape of the global biobanking cold storage equipment market is dominated by several key players, each offering cutting-edge technologies to meet the growing demand for reliable cold storage solutions. Leading companies such as Thermo Fisher Scientific, Inc., Azenta, Inc., and PHC Holding Corporation are at the forefront, providing a wide range of equipment including freezers, cryogenic storage systems, and refrigerators that cater to diverse biobanking needs. Other prominent players like Haier Biomedical, Eppendorf SE, and Trane Technologies plc offer specialized cold storage systems designed to meet the rigorous demands of biobanks. The market is highly competitive, with these players continually advancing their product portfolios by integrating digital technologies like cloud-based monitoring and automation. Companies such as MGI Tech Co., Ltd, Arctiko, Labcold, Esco Micro Pte. Ltd, Avantor, Inc., BioLife Solutions, Inc., Hamilton Company, and IC Biomedical, LLC also contribute to the market through innovation and strategic partnerships, positioning themselves as strong contenders in this growing industry.
Some prominent names established in the global biobanking cold storage equipment market are:
Scope and Definition